FORUM Institut - US MFN Drug Pricing & European Market Access: Strategic Briefing for 2027

Adem Koyuncu will present "What MFN means for European pricing and International Reference Pricing." This seminar provides pricing, market access and regulatory professionals with a structured and expert-guided overview of the US MFN policy landscape and its consequences for European pharmaceutical pricing. Participants gain a clear understanding of the proposed GUARD and GLOBE models, their interaction with International Reference Pricing, and the strategic implications for global launch sequencing ahead of 2027.

Click here for additional information and to register.